Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by D A Rizzieri
Prognostic Factors for Outcomes in Allogeneic Transplantation for CML in the Imatinib Era: A CIBMTR Analysis
Bone Marrow Transplantation
Transplantation
Hematology
High-Dose BCNU/Melphalan Conditioning Regimen Before Autologous Stem Cell Transplantation in Newly Diagnosed Multiple Myeloma
Bone Marrow Transplantation
Transplantation
Hematology
Related publications
Improving Outcomes After Allogeneic Hematopoietic Cell Transplantation for Hodgkin Lymphoma in the Brentuximab Vedotin Era
Bone Marrow Transplantation
Transplantation
Hematology
Outcomes for Reduced-Intensity Allogeneic Transplantation for Multiple Myeloma: An Analysis of Prognostic Factors From the Chronic Leukaemia Working Party of the EBMT
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Prognostic Factors and Outcomes of Severe Gastrointestinal GVHD After Allogeneic Hematopoietic Cell Transplantation
Bone Marrow Transplantation
Transplantation
Hematology
Outcome and Prognostic Factors for Patients Who Relapse After Allogeneic Stem Cell Transplantation.
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Prognostic Factors for Mortality Among Day 100 Survivors After Allogeneic Hematopoietic Cell Transplantation
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
The Influence of Early Transplantation, Age, GVHD Prevention Regimen, and Other Factors on Outcome of Allogeneic Transplantation for CML Following BuCy
Bone Marrow Transplantation
Transplantation
Hematology
Long-Term Survival With CML With Imatinib or Transplantation as First-Line Treatment: Comparison of Outcomes From CML Studies IIIA and IV
Cellular Therapy and Transplantation
Transplantation
Molecular Medicine
Application of the CIBMTR Survival Outcomes Calculator to CD34-Selected Allogeneic HCT for Acute Leukemia and Myelodysplastic Syndrome
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Reduced-Intensity Allogeneic Transplantation Combined With Imatinib Mesylate for Chronic Myeloid Leukemia in First Chronic Phase
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
